CARDIOVASCULAR DISEASE IN HIV
Abstract
People living with HIV are at increased risk for cardiovascular disease. This report summarizes our work demonstrating associations between HIV and multiple subclinical markers of cardiovascular disease risk. Some of this risk appears to be related to heightened immune activation and system inflammation that is present in people living with HIV even when there is an undetectable viral load.
© 2022 The American Clinical and Climatological Association.
Similar articles
-
Inflammatory Biomarkers and Carotid Thickness in HIV Infected Patients under Antiretroviral Therapy, Undetectable HIV-1 Viral Load, and Low Cardiovascular Risk.Arq Bras Cardiol. 2020 Jan;114(1):90-97. doi: 10.5935/abc.20190230. Arq Bras Cardiol. 2020. PMID: 31664319 Free PMC article.
-
Cardiovascular Disease, Statins, and HIV.J Infect Dis. 2016 Oct 1;214 Suppl 2(Suppl 2):S83-92. doi: 10.1093/infdis/jiw288. J Infect Dis. 2016. PMID: 27625435 Free PMC article. Review.
-
Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy.Front Immunol. 2019 Aug 27;10:1965. doi: 10.3389/fimmu.2019.01965. eCollection 2019. Front Immunol. 2019. PMID: 31507593 Free PMC article.
-
Inflammation, immune activation, and cardiovascular disease in HIV.AIDS. 2016 Jun 19;30(10):1495-509. doi: 10.1097/QAD.0000000000001109. AIDS. 2016. PMID: 27058351 Free PMC article. Review.
-
Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease Risk.Front Immunol. 2021 Jul 5;12:647805. doi: 10.3389/fimmu.2021.647805. eCollection 2021. Front Immunol. 2021. PMID: 34290695 Free PMC article. Clinical Trial.
References
-
- Palella FJ, Jr., Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43((1)):27–34. - PubMed
-
- Wada N, Jacobson LP, Cohen M, French A, Phair J, Munoz A. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984–2008. Amer J Epidem. 2013;177((2)):116–25. - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical